BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CCMG | CCGM - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ccmg.51-222-78-205.ygkweb.ca
X-WR-CALDESC:Events for CCMG | CCGM
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250117T110000
DTEND;TZID=America/Toronto:20250117T120000
DTSTAMP:20260628T171248
CREATED:20250106T174236Z
LAST-MODIFIED:20250109T191750Z
UID:10000065-1737111600-1737115200@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_7trryYsQRROjpvFp0VoSHw.  \n \n  \n  \n  \n  \n2024-2025 TeleGraf from 11:00am – 12:00pm ET\, scheduled dates are: \nFriday\, October 18\, 2024 \nFriday\, November 15\, 2024 – to be rescheduled \nFriday\, December 20\, 2024 \nFriday\, January 17\, 2025 \nThere will be 2 TeleGraf presentations on January 17th. \n11:00-12:00 – Alkaptonuria: Review of Its Chronic And (rare) Acute Complications \nAlkaptonuria was one of Garrod’s original four inborn errors of metabolism. Chronic complications of the condition are well\nrecognized and there is some evidence to inform management approaches. However\, acute complications of Alkaptonuria are\nrare and poorly recognized. In this presentation I will review Alkaptonuria with a focus on rare acute presentations of the\ndisease. \nSpeaker: Dr. Chris Smith \nBio \nDr. Chris Smith was born and raised in Calgary\, Alberta\, where he undertook the majority of his training and presently resides.\nHe earned a Bachelor of Health Sciences from the University of Calgary before matriculating to the Cumming School of\nMedicine Leaders in Medicine Program\, graduating from the combined MD/MSc program in 2019. He completed a 5-year Royal\nCollege Residency in Medical Genetics & Genomics at the Alberta Children’s Hospital. Now in his first year of practice Dr. Smith\npractices in pediatric and prenatal genetics while training part time in clinical biochemical genetics. \n12:30-1:30 – The Launch of the Silent Genomes Indigenous Background Variant Library: Building the Path to Genetic and Genomic Equity for Indigenous Patients. \nAt the end of this session\, participants will be able to: \n\nidentify three contributors to health disparity for genetic diagnosis and genetic health care in Canada.\ncite the Global Indigenous Data Alliance Care Principles for upholding Indigenous Rights and Interests in the context of genomic data.\nhave the tools to access the Silent Genomes Project Indigenous background variant library to obtain variant frequency information for their Indigenous patients.\n\nSpeaker: Dr. Laura Arbour \nBio \nDr. Laura Arbour. MSc\, MSc\, MD\, FRCPC\, FCCMG is a Professor in the Department of Medical Genetics at the University of British Columbia situated at the Island Medical Program in Victoria BC where she is also a clinician. Trained as both pediatrician and clinical geneticist\, she has been addressing the genetic determinants of health with Indigenous populations for more than three decades. Through her UBC Community Genetics Research Program she has focused on rare\, single gene disorders and complex conditions in partnership with First Nations of BC and Inuit of Nunavut. Her research has been continuously funded since 2004 through such funders as the Canadian Institutes of Health Research\, Genome Canada\, Genome BC including the recent Silent Genomes Project (2018-2024)\, co-led by Dr’s Wyeth Wasserman and Nadine Caron addressing inequity in genomic diagnosis for Indigenous patients of Canada. \nFriday\, February 21\, 2025 \nFriday\, March 21\, 2025 \nFriday\, April 11\, 2025 \nFriday\, May 16\, 2025 \nFriday\, June 20\, 2025
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/telegraf-2-3/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250117T123000
DTEND;TZID=America/Toronto:20250117T133000
DTSTAMP:20260628T171248
CREATED:20240917T193028Z
LAST-MODIFIED:20250613T155412Z
UID:10000070-1737117000-1737120600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:TeleGraf
DESCRIPTION:About this series – Telehealth for Genetics Residents and Fellows. A monthly teaching session brought to you by the members of the RCPSC Specialty Committee in Medical Genetics. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_7trryYsQRROjpvFp0VoSHw.  \n \n  \n  \n  \n  \n2024-2025 TeleGraf from 11:00am – 12:00pm ET\, upcoming dates are:\nFriday\, June 20\, 2025\nAutoinflammatory Disorders\nThis presentation will provide an overview of the different autoinflammatory disorders\, including the monogenic forms.\n \nSpeaker: Dr. Hugo Chapdelaine \n \nDr. Hugo Chapdelaine is in charge of the Adult Clinical Immunology program at the Montreal Clinical Research Institute. He is clinical associate professor at Université de Montréal.
URL:https://ccmg.51-222-78-205.ygkweb.ca/%tribe_events_slug%/telegraf-2/2025-01-17/
CATEGORIES:TeleGraf
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250124T120000
DTEND;TZID=America/Toronto:20250124T130000
DTSTAMP:20260628T171248
CREATED:20250106T174829Z
LAST-MODIFIED:20250106T174829Z
UID:10000071-1737720000-1737723600@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:CCMG Webinar – Presented by Illumina
DESCRIPTION:Collaboration between Industry\, Societies and other Stakeholders to Increase Access to Genetic Services \nAt the end of this session\, participants will be able to:\n• identify a few collaborations between industry and medical societies and the outcomes of these;\n• describe the benefits of working with diverse stakeholders; and\n• propose ideas for potential collaboration with industry or other organizations. \nSpeaker: Melissa Dempsey \nBio \nMelissa began her career as a clinical and lab genetic counselor at the University of Chicago. She then moved to her hometown in Indiana\, where she built a Genetic Counseling Clinic for both oncology and cardiology patients. Melissa’s desire for a larger impact moved her to industry\, as she worked to expand genomic services through marketing at two major diagnostic laboratories. She also led the Global Customer Success Team for Face2Gene software\, an AI platform that aids clinicians in diagnosing children with rare genetic diseases via facial recognition. \nWorking in Market Development for Illumina\, Melissa seeks creative ways to increase access to genetic testing through larger projects and thoughtful collaborations. She loves building relationships with experts and sharing her vision for routine genomic testing as an integral part of medical care.
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/ccmg-webinar-presented-by-illumina-2/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20250131T120000
DTEND;TZID=America/Toronto:20250131T130000
DTSTAMP:20260628T171248
CREATED:20250114T170054Z
LAST-MODIFIED:20250114T170143Z
UID:10000057-1738324800-1738328400@ccmg.51-222-78-205.ygkweb.ca
SUMMARY:Can-GARD/CCMG – The Leading Strand Series
DESCRIPTION:This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers\, clinicians and innovators.  The series will help attendees anticipate\, access\, and apply new approaches and technologies for patient care. \nThe Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada. \nTo register\, click the button below or go to https://us06web.zoom.us/webinar/register/WN_MzE5qgCSQCyPI-X9Ys7_IQ  \n \n  \n  \n  \n  \n2024-2025 Leading Strand from 12:00pm – 1:00pm ET\, scheduled dates are: \nFriday September 27\, 2024 \nFriday October 25\, 2024 \nFriday November 22\, 2024 \nFriday December 13\, 2024 – cancelled \nFriday\, January 31\, 2025 \nLiver-Directed Gene Therapy for Inherited Metabolic Disorders \nLearning objectives: \n\nQuote the most commonly used vectors for liver-directed gene therapy.\nAssess the safety and efficacy of gene therapy\, especially for inherited metabolic diseases.\nUnderstand the current limitations and issues of liver-directed gene therapy.\n\nDescription of talk: \nInherited metabolic diseases (IMD) are disorders affecting human biochemical pathways and represent attractive targets for gene therapy because of their severity\, high overall prevalence\, lack of effective treatments\, and possibility of early diagnosis through newborn screening. The liver is a central organ involved in several metabolic reactions and is a favorite target for gene therapy in many IMD. Adeno-associated virus (AAV) vectors have emerged in the last years as the preferred vectors for in vivo gene delivery. Gene replacement strategies are aimed either at correcting liver disease or providing a source for production and secretion of the lacking enzyme for cross-correction of other tissues. A number of preclinical studies have been conducted in the last two decades and\, for several diseases\, gene therapy has reached the clinical stage. In my talk\, our experience on two ongoing clinical gene therapy trials for IMD and I will highlight current obstacles and future strategies to overcome them. \nSpeaker: Dr. Nicola Brunetti \nBio: \nNicola Brunetti-Pierri graduated in Medicine and trained in Pediatrics at University of Naples Federico II. He then moved to Baylor College of Medicine\, Houston\, TX for a post-doctoral fellowship and clinical training in Medical Genetics and Biochemical Genetics. He was assistant professor in the Department of Molecular and Human Genetics of Baylor College of Medicine until he returned to Italy. As a physician-scientist his research goals are to elucidate the pathogenetic mechanisms and develop effective therapies for genetic diseases. He identified several new genetic diseases and generated proof-of-concept studies for new therapies in genetic disorders. He received awards from ASGCT and ESGCT and fundings by NIH and ERC. He is the principal investigator of phase 1/2 gene therapy clinical trials. He is Professor of Pediatrics at Federico II University of Naples\, Principal Investigator at the Telethon Institute of Genetics and Medicine (TIGEM)\, Italy. \nFriday February 28\, 2025 \nFriday\, March 28\, 2025 \nFriday\, April 25\, 2025 \nFriday\, May 30\, 2025 \nFriday June 27\, 2025 \nFriday\, May 16\, 2025 \nFriday\, June 20\, 2025
URL:https://ccmg.51-222-78-205.ygkweb.ca/event/can-gard-ccmg-the-leading-strand-series-3-5/
ORGANIZER;CN="CCMG | CCGM":MAILTO:info@ccmg-ccgm.org
END:VEVENT
END:VCALENDAR